Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487071 | 12548707 | 1 | I | 20160616 | 0 | 20160711 | 20160711 | DIR | 44.00 | YR | F | N | 140.00000 | LBS | 20160710 | Y | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125487071 | 12548707 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | N | D | 0 | 175 | IU | |||||||
| 125487071 | 12548707 | 11 | C | MACROBID | NITROFURANTOINNITROFURANTOIN MONOHYDRATE | 1 | 175 UNITS | 0 | |||||||||||
| 125487071 | 12548707 | 13 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 15 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 17 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 19 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 21 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 23 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 25 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 27 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 29 | C | MULTI-VITAMIN | .ALPHA.-TOCOPHEROL ACETATE, DL-ASCORBIC ACIDCYANOCOBALAMINFLUORIDE IONFOLIC ACIDNIACINPYRIDOXINERIBOFLAVINTHIAMINEVITAMIN AVITAMIN D | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 31 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 33 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 35 | C | TURMERIC | TURMERIC | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 37 | C | CALCIUM-D | 2 | 0 | |||||||||||||
| 125487071 | 12548707 | 39 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125487071 | 12548707 | 41 | C | OMEGA 3-6-9 | FISH OIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125487071 | 12548707 | 1 | Migraine |
| 125487071 | 12548707 | 1 | Torticollis |
| 125487071 | 12548707 | 11 | Migraine |
| 125487071 | 12548707 | 11 | Torticollis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125487071 | 12548707 | OT |
| 125487071 | 12548707 | LT |
| 125487071 | 12548707 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125487071 | 12548707 | Arrhythmia | |
| 125487071 | 12548707 | Asthenia | |
| 125487071 | 12548707 | Autonomic nervous system imbalance | |
| 125487071 | 12548707 | Botulism | |
| 125487071 | 12548707 | Dysphagia | |
| 125487071 | 12548707 | Dyspnoea | |
| 125487071 | 12548707 | Facial paralysis | |
| 125487071 | 12548707 | Fatigue | |
| 125487071 | 12548707 | Iatrogenic injury | |
| 125487071 | 12548707 | Impaired gastric emptying | |
| 125487071 | 12548707 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125487071 | 12548707 | 1 | 20160615 | 0 |